Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Bai

Showing results (501-510 of 518) with videos related to

Pageof 52
Sort By:
The International Journal of Biological Markers|April 18, 2013
Comparative evaluation of cytokines in gingival crevicular fluid and saliva of patients with aggressive periodontitisYuan Yue, Qing Liu, Chunjiao Xu, et al.
The International Journal of Biological Markers|July 22, 2014
Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancerYan-jun Wang, Ling He, Ming Yuan, et al.
Zhonghua Yi Xue Za Zhi|February 26, 2005
[Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation]Yan Zhao, Dao-bin Zhou, Xiao-mei Leng, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|November 12, 2005
[A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia]Zheng Li, Guo-wu Chen, Xue-jun Shang, et al.
Bioactive Materials|March 21, 2023
Dual-bionic regenerative microenvironment for peripheral nerve repairYanjun Guan, Zhiqi Ren, Boyao Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2019
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II TrialLi Li, Liyan Jiang, Yubo Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2025
Acupuncture effect on brain default mode network connectivity in breast cancer patients with hot flashes: A randomized controlled trialZhuo-Nan Wang, Gui-Hua Tian, Jie-Rui Ding, et al.
Emerging Infectious Diseases|July 22, 2022
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic StudiesMichael Loesche, Elizabeth W Karlson, Opeyemi Talabi, et al.
Transplantation and Cellular Therapy|May 8, 2022
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release SyndromeJessica S Little, Roman M Shapiro, Muneerah M Aleissa, et al.
World Journal of Gastrointestinal Oncology|September 2, 2022
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinomaXi Wang, Cheng-Sheng Zhang, Xu-Yuan Dong, et al.
Pageof 52

Showing results (501-510 of 518) with videos related to

Sort By:
Pageof 52
The International Journal of Biological Markers|April 18, 2013
Comparative evaluation of cytokines in gingival crevicular fluid and saliva of patients with aggressive periodontitisYuan Yue, Qing Liu, Chunjiao Xu, et al.
The International Journal of Biological Markers|July 22, 2014
Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancerYan-jun Wang, Ling He, Ming Yuan, et al.
Zhonghua Yi Xue Za Zhi|February 26, 2005
[Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation]Yan Zhao, Dao-bin Zhou, Xiao-mei Leng, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|November 12, 2005
[A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia]Zheng Li, Guo-wu Chen, Xue-jun Shang, et al.
Bioactive Materials|March 21, 2023
Dual-bionic regenerative microenvironment for peripheral nerve repairYanjun Guan, Zhiqi Ren, Boyao Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2019
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II TrialLi Li, Liyan Jiang, Yubo Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2025
Acupuncture effect on brain default mode network connectivity in breast cancer patients with hot flashes: A randomized controlled trialZhuo-Nan Wang, Gui-Hua Tian, Jie-Rui Ding, et al.
Emerging Infectious Diseases|July 22, 2022
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic StudiesMichael Loesche, Elizabeth W Karlson, Opeyemi Talabi, et al.
Transplantation and Cellular Therapy|May 8, 2022
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release SyndromeJessica S Little, Roman M Shapiro, Muneerah M Aleissa, et al.
World Journal of Gastrointestinal Oncology|September 2, 2022
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinomaXi Wang, Cheng-Sheng Zhang, Xu-Yuan Dong, et al.
Pageof 52